FDAClass II · Drug · Recalled June 24, 2026

Vasopressin 2 Units/2 mL in 0 recall — IntegraDose Compounding Services LLC

Hazard: Subpotent Drug

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0593-2026
Brand: IntegraDose Compounding Services
Classification: Class II
Units affected: 287 units
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

Affected products

Vasopressin 2 Units/2 mL in 0

Companies & origin

Recalling firm location: Shoreview, MN, United States
Firm address: 3650 Victoria St N Ste 900, 55126-2906

Identifying details (verbatim from the notice)

Product codes / lots: Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.
Distribution: U.S.A. Nationwide
Firm notified the public via: Letter
FDA event ID: 99014
Recall initiated: May 18, 2026
FDA classified: June 12, 2026
FDA report date: June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page